相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Functional Gadofullerene Nanoparticles Trigger Robust Cancer Immunotherapy Based on Rebuilding an Immunosuppressive Tumor Microenvironment
Lei Li et al.
NANO LETTERS (2020)
Multifunctional Nanoparticles Boost Cancer Immunotherapy Based on Modulating the Immunosuppressive Tumor Microenvironment
Ji Li et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Hybrid polymeric nanoparticles with high zoledronic acid payload and proton sponge-triggered rapid drug release for anticancer applications
Min-Cong Xiao et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2020)
Synergetic Functional Nanocomposites Enhance Immunotherapy in Solid Tumors by Remodeling the Immunoenvironment
Linnan Yang et al.
ADVANCED SCIENCE (2019)
Tumor Microenvironment-Triggered Aggregated Magnetic Nanoparticles for Reinforced Image-Guided Immunogenic Chemotherapy
Qinjun Chen et al.
ADVANCED SCIENCE (2019)
Multifunctional drug carrier based on PEI derivatives loaded with small interfering RNA for therapy of liver cancer
Yarong Zhao et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Transcellular transfer of nanomedicine
Hae Lin Jang et al.
NATURE NANOTECHNOLOGY (2019)
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
Xiaopin Duan et al.
NATURE COMMUNICATIONS (2019)
Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
Alfonso Serrano-del Valle et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Reprogramming the T cell response to cancer by simultaneous, nanoparticle-mediated PD-L1 inhibition and immunogenic cell death
Cao Dai Phung et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Tumor targeting via EPR: Strategies to enhance patient responses
Susanne K. Golombek et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy
Flavia Radogna et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment
Bing Feng et al.
ADVANCED MATERIALS (2018)
De-novo and acquired resistance to immune checkpoint targeting
Nicholas L. Syn et al.
LANCET ONCOLOGY (2017)
Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
Andrew L. Mellor et al.
FRONTIERS IN IMMUNOLOGY (2017)
Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers
Wenjing Zheng et al.
ACTA BIOMATERIALIA (2016)
Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy
Xiao Zhao et al.
BIOMATERIALS (2016)
Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors
Golam Kibria et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Big opportunities for small molecules in immuno-oncology
Jerry L. Adams et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
Rikke B. Holmgaard et al.
CELL REPORTS (2015)
Immunological hallmarks of stromal cells in the tumour microenvironment
Shannon J. Turley et al.
NATURE REVIEWS IMMUNOLOGY (2015)
TLR4-dependent activation of dendritic cells by an HMGB1-derived peptide adjuvant
Rebecca Saenz et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Barriers to drug delivery in solid tumors
Shravan Kumar Sriraman et al.
TISSUE BARRIERS (2014)
Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine
Hui-Ming Chen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity
Xiangdong Liu et al.
BLOOD (2010)
alpha,beta-Poly(L-aspartate-graft-PEI): A pseudo-branched PEI as a gene carrier with low toxicity and high transfection efficiency
Jia-Hui Yu et al.
ACTA BIOMATERIALIA (2009)
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Fernando O. Martinez et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo
Huanjie Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Creating immune privilege: active local suppression that benefits friends, but protects foes
Andrew L. Mellor et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Shikonin circumvents cancer drug resistance by induction of a necroptotic death
Weidong Han et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Progress in human tumour immunology and immunotherapy
SA Rosenberg
NATURE (2001)
分享论文
